Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1961 1
1962 3
1964 4
1965 3
1967 2
1968 2
1972 1
1974 1
1975 1
1976 6
1977 5
1978 14
1979 25
1980 15
1981 14
1982 19
1983 27
1984 18
1985 19
1986 44
1987 27
1988 30
1989 40
1990 43
1991 38
1992 47
1993 36
1994 57
1995 47
1996 47
1997 44
1998 46
1999 65
2000 73
2001 77
2002 83
2003 106
2004 75
2005 90
2006 75
2007 95
2008 82
2009 81
2010 93
2011 79
2012 100
2013 106
2014 96
2015 106
2016 113
2017 87
2018 109
2019 95
2020 142
2021 117
2022 110
2023 116
2024 41

Text availability

Article attribute

Article type

Publication date

Search Results

2,891 results

Results by year

Filters applied: . Clear all
Page 1
Relationship of oral bacterial number with medical hospitalization costs in analysis of Diagnosis Procedure Combination database from single institution in Japan.
Nishi H, Kajiya M, Ohta K, Shigeishi H, Obayashi T, Munenaga S, Obayashi N, Yoshioka Y, Konishi M, Naruse T, Matsumoto A, Odo A, Kitagawa M, Ando T, Shintani T, Tokikazu T, Ino N, Mihara N, Kakimoto N, Tsuga K, Tanimoto K, Ohge H, Kurihara H, Kawaguchi H. Nishi H, et al. Among authors: ohta k. Sci Rep. 2024 May 15;14(1):11114. doi: 10.1038/s41598-024-60733-z. Sci Rep. 2024. PMID: 38750118
Effects of Ninjin'yoeito on Patients with Chronic Obstructive Pulmonary Disease and Comorbid Frailty and Sarcopenia: A Preliminary Open-Label Randomized Controlled Trial.
Ohbayashi H, Ariga M, Ohta K, Kudo S, Furuta O, Yamamoto A. Ohbayashi H, et al. Among authors: ohta k. Int J Chron Obstruct Pulmon Dis. 2024 May 7;19:995-1010. doi: 10.2147/COPD.S441767. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38737191 Free PMC article. Clinical Trial.
Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy.
Miyamoto A, Michimae H, Nakahara Y, Akagawa S, Nakagawa K, Minegishi Y, Ogura T, Hontsu S, Date H, Takahashi K, Homma S, Kishi K; Investigators Group for Lung Cancer and IIP. Miyamoto A, et al. Sci Rep. 2024 May 3;14(1):10162. doi: 10.1038/s41598-024-60833-w. Sci Rep. 2024. PMID: 38702426 Free PMC article.
Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study.
Suzukawa M, Ohta K, Sugimoto M, Ohshima N, Kobayashi N, Tashimo H, Tanimoto Y, Itano J, Kimura G, Takata S, Nakano T, Yamashita T, Ikegame S, Hyodo K, Abe M, Chibana K, Kamide Y, Sasaki K, Hashimoto H. Suzukawa M, et al. Among authors: ohta k. Allergol Int. 2024 Apr 23:S1323-8930(24)00047-9. doi: 10.1016/j.alit.2024.04.003. Online ahead of print. Allergol Int. 2024. PMID: 38658257 Free article.
2,891 results